In 2013, a record $29.3 billion was spent on prescription drugs in Canada
- The public sector finances roughly 40% of prescribed drug spending in Canada, with the remainder financed by private insurers and individuals.
- Drugs used to treat conditions related to the cardiovascular or nervous system accounted for roughly 40% of public drug spending. Nervous system drugs include treatment for mental health conditions and for pain.
Per person, Canada is second only to the U.S. in spending on prescription drugs
- Spending on prescribed drugs in Canada has increased every year since 1985.
- Even though the amount of money Canadians spent on drugs rose in 2013, the annual rate of growth – 2.3% – was the second-lowest in more than two decades.
The majority of public drug spending is for a small number of high-cost individuals
- Almost half of these people are taking high-cost drugs used to treat conditions such as rheumatoid arthritis, Crohn's disease and macular degeneration.
The slowed growth in spending is due, in part, to the increased use of less-expensive generic drugs
- The use of generics is increasing because several of the most commonly prescribed drugs are now available in generic form.
- Generic drugs account for the majority of use but less than half of spending in public drug programs.
Sources: Prescribed Drug Spending in Canada, 2012: A Focus on Public Drug Programs Canadian Institute for Health Information (CIHI)
Be the first to comment on this!
Personal Subscriber? Sign In
Note: Please enter a display name. Your email address will not be publically displayed